Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.
The researchers believe their work could enable Oxford’s ChAdOx vaccines to hit the “moonshot” objective set earlier this year by the Coalition for Epidemic Preparedness Innovations (CEPI), which aims to help compress vaccine development timelines to 100 days from pathogen identification to mass
Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant
Researchers from the University of Oxford have analysed the impact of the Omicron COVID-19 variant of concern on one of the immune responses generated by vaccination.
Featuring notable speakers from across the fields of business, science or politics almost every year since 1972, Prof.
Professors Dame Sarah Gilbert, Teresa Lambe, Sir Andrew Pollard and Fiona Powrie received the awards for contributions to the field of immunology, from developing the ChAdOx1 nCoV-19 coronavirus vaccine to pioneering gut immunology research and have inspired scores of new immunologists in the fie
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
The accolade is one of a selection of prizes and medals awarded today by the British Academy, the national body for the humanities and social sciences, for notable contributions to fields including Linguistics, Cultural History and Biblical Studies and is shared with Gillian Russell, Professor of
AstraZeneca, with their extensive world-wide development and manufacturing capabilities, have been able to have the vaccine approved and licenced for use in over 170 countries, with over 20 manufacturing sites across the world, including the Serum Institute of India, working together to release t
The trial, funded by Innovate UK, part of UK Research and Innovation https://www.ukri.org/, uses a vaccine based on the ChAdOx1 adenovirus viral vector platform al
The independent study, sponsored by the Department of Health and Social Care and supported by the Department for Education and Office for National Statistics, ran between April and June 2021.
Hearing impairment affects around 1.5 billion individuals worldwide (World Health Organization), and there is growing evidence that this could increase the risk of dementia.
Globally coronary heart diseases (caused by narrowed arteries that supply the heart with blood) claim nearly nine million lives each year1, the largest of any disease, and present a huge burden to health systems.
Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the i
A new study by researchers at the University of Oxford, Queen Mary University of London, Institute for Advanced Studies, Vienna, and the Medical University of Graz, has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used at th
High levels of glucose in the blood ‘reprogrammes’ stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research funded by the British Heart Foundation published today in Circulation.